Introduction: Respiratory disease remains one of the leading causes of mortality
| INTRODUCTION
Respiratory disorders remain a significant burden worldwide. Globally, 2 of the 5 leading causes of total years of life lost in 2016 were respiratory related. 1 Pulmonary disease accounts for 17% of disability-adjusted life years and may be the top cause of death in the world. 2, 3 Over the past decades, China has witnessed impressive economic evolution and urbanization progress. The rapid economic growth in China is accompanied by serious air pollution, which poses a great threat to human health. 4 Air pollution is a major environmental problem affecting the health of respiratory system. 5 Besides, with a population of more than 1.3 billion, China has become one of countries with the greatest respiratory disease burden in world. 6 Articles have compared publications between Mainland China (MC), Hong Kong and Taiwan in the field of respirology. 7 However, little is known about the research status of respirology in MC compared with the other top-ranking countries. Bibliometrics is a viable means to evaluate the literature quantitatively and qualitatively, and to assess the trends in research activity over time. 8 In this study, we conducted a 11-year survey of literature and compared the contributions of MC researchers with contributions from the top 4 most published countries in the field of respirology between 2007 and 2017. We aimed to investigate the evolution of respiratory studies in the 5 countries, and to provide a more accurate way to assess the development status of respirology in MC. We also investigated whether gross domestic product (GDP) influences respiratory research productivity from the 5 countries.
| METHODS
In this bibliometric study, a total of 58 journals were selected from the 'respiratory system' category of Science Citation Index Expanded (SCIE) designed by Thomson Reuters. All of the 58 journals in the respiratory category, which could be retrieved by Web of Science and PubMed, cover resources dealing with the diagnosis and treatment of respiratory disease and focuses on pharmacology, surgery, transplantation, prevention and research. Although other respiratory articles may also be published in other journals, publications in these 58 journals represent the majority of scientific output in the field of respirology. The details of the 58 journals are listed in the supporting information Table S1 . Data search and extraction process was conducted by 2 independent researchers (YQ and CZ), and discrepancy of results was resolved though discussion. A computerized literature search was conducted on August 1, 2018, and the articles published from January 1, 2007 to December 31, 2017 in these journals were retrieved. The respiratory articles from MC, the United States, the United Kingdom, Canada and Germany were identified using the first author's institutional affiliations. We used the ISSN numbers to perform searches in PubMed. The search terms used were shown in the supporting information. Additionally, only English articles were included in this study. The numbers of each specific type of article such as clinical trials, randomized controlled trials (RCTs), case reports, meta-analysis and reviews were calculated using data obtained from the PubMed.
To compare the quality and quantity of the research articles, 4 methods were used. First, the accumulated impact factors (IF) and the average IF (Cumulative IF divided by total number of articles) were calculated according to Journal Citation Reports (JCR) 2017 published by Thomson Reuters. Second, citation reports for the literature from 5 countries were collected through Web of Science. Third, the number of articles published by each region in the top 10 highimpact respiratory journals were counted and the 10 most popular respiratory journals for each region were also identified. Finally, the h-index for each region was calculated. It measures both the productivity and citation impact of publications by a region or a scientist.
| Statistical analysis
Statistical analyses were performed using SPSS 19.0 software (SPSS, Chicago, Illinois). Kruskal-Wallis test was used to detect the differences among the 5 countries, and rank-sum test between 2 countries, if necessary. The test for significance was 2-tailed and the value of P < 0.05 was considered significant.
| RESULTS

| Total amount and share of publications
A total number of 93 078 articles were published in the selected 58 journals within the period 2007-2017 worldwide. As shown in Figure 1A , authors from the United States produced the highest number of articles (34 399, 37.0%, 1st in the world), followed by the United Kingdom (9494, 10.2%, 2nd), Germany (6918, 7.4%, 3rd) and Canada (6574, 7.1%, 4th). MC accounts for 6. 
| Publication activity in relation to socioeconomic factors
Previous studies showed that the socioeconomic factor GDP strongly influenced the number of publications in the urology and the transplantation field, so we investigated whether GDP correlates with the respirology publications in the 5 countries. As illustrated in Figure 2 , there were positive correlations between the annual number of respirology publications with GDP in MC (r = 0.97, P < 0.0001), Canada (r = 0.61, P < 0.05) and the United States (r = 0.84, P < 0.05). However, the annual number of publications did not correlate with GDP in the United Kingdom and Germany.
| Publication types
The number of different article types published by each country, which include reviews, clinical trials, case reports, meta-analysis and RCTs, were shown in Figure 3 . The United States has the largest share and highest quality of all types of articles except meta-analysis. The total number of clinical trials from MC was remarkably lower than that from the other countries. Similar phenomenons were found in reviews and RCTs. However, MC has published the largest number of meta-analysis among the 5 countries in the past decade. In addition, MC had published more case reports than Canada for the last 11 years in total. The annual number of 5 article types published by each country were shown in Figure 4 . Since 2013, the number of clinical trials, RCTs, and case reports published in the United States has reduced significantly, especially the case reports. Except for the increase in the number of meta-analysis and reviews since 2013, there have been no significant changes in the other 4 types of articles published in MC.
| Impact factors
According to the JCR, 57 journals in the 'respiratory system' had IF in 2017. As seen in Table 1 , the accumulated IF of articles from MC (22 224) was much lower than those from the United States (163 116, P < 0.001), the United Kingdom (54 255, P < 0.001), Germany (33 961, P = 0.002) and Canada (32 711, P = 0.003). However, the United Kingdom took the highest average IF of 5.7, followed by Canada of 5.0, Germany of 4.9 and the United States of 4.7. MC's average IF was much lower than that of the other 4 countries (3.6, P < 0.001). In addition, the average IF of MC decreased year by year. And there was a strong negative correlation between MC's average IFs and the annual number of articles (r = 0.93, P < 0.0001).
| Citation reports and H-index
As shown in Table 2 , the United States had the highest total citations and Canada had the highest average number of citations per article over the past 11 years, while MC had the lowest total or average number of citations. Citations to articles from the 5 countries remained stable from 2009 to 2012. But since 2013, the number of citations in 5 countries has declined year by year, and the United States had a faster drop than the other 4 countries. Since 2014, the gap between MC and Germany or Canada has narrowed. As shown in the supporting information Figure S1 , the United States had the highest value of H-index (206), followed by the United Kingdom (156), Canada (140), Germany (130) and MC (78). (13 362, 53 .9%) in the 10 top-ranking respiratory journals, followed by the United Kingdom (4452, 18.0%), Canada (2833, 11.4%), Germany (2453, 9.9%) and MC (1690, 6.8%). The United States had the biggest share, far more than the combination of the other 4 countries. In addition, 39.3% of US articles are published in the top 10 high-impact journals, 46.9% in the United Kingdom, 35.5% in Germany and 43.1% in Canada, while only 27.0% from MC were published in those journals (Table 3) .
| Popular respiratory journals
The details for the top 10 most published journals in each country are listed in the supporting information 
T A B L E 2 Total and average citations of articles from the 5 countries
Canada, 4 journals in Germany, and 6 journals in MC were ranked in the top 10 high-impact journals. Over 11 years, J Thorac Dis ranked the first in MC. And more than 30% of the articles were published in this journal. However, the IF of J Thorac Dis was the lowest among top 1 journals in 5 countries.
| DISCUSSION
To the best of our knowledge, this is the first study to systematically analyse the contribution of authors from MC and other top-ranking countries to respiratory research. It is unrealistic to compare the scientific output of MC with all the countries in the world. Therefore, we only focused on the top 4 scientific powers. These 4 countries had the largest scientific publications in the world and were also among the top 20 areas with the highest GDP.
Our study compared the number and quality of scientific publications in the field of respirology by MC and the United States, the United Kingdom, Germany and Canada. There is no doubt that the total and annual numbers of respiratory publications from the United States were the highest in the world. Although the number of articles from the United States has increased since 2009, the annual share of articles has declined. In the past 11 years, the annual number and share of published articles remained steady in highly developed countries including the United Kingdom, Germany and Canada. It is worth noting that the number and share of articles published each year in MC have increased significantly. The number of articles from MC in 2017 reached almost 6 times the quantity of 2007 and that number has exceeded Germany and Canada since 2013 and has surpassed the United Kingdom in 2016. We then observed that GDP showed a strongly positive correlation with the annual number of articles. One reason for this is the sustained rapid economic growth in MC and the United States. With the continuous growth of GDP, the government has increased its investment in scientific research. Other factors such as job promotion needs and incentive rewards programmes would certainly stimulate research results. 9 But given the relative size of the populations, MC lagged far behind the highly developed countries in the field of respirology. However, it has to be mentioned that the correlation between GDP and publications should be carefully interpreted, as the GDP growth in other countries is much smaller than in the United States and MC, so the correlation will be weaker. Well-designed, conducted and reported RCTs represent the gold standard in assessing health-care intervention. 10 Researchers from the United States published the largest number of clinical trials, RCTs, reviews and case reports during 2007-2016. It is worth mention that authors from 13, 14 It should also be mentioned that IFs are not the only or optimal parameters to identify the quality of articles. 15 It is possible that articles published in journals with low IFs may be good works, and the opposite could also be the case. Therefore, we further used citations of articles and h-index as objective parameters to evaluate the quality of publications from various countries. The number of times an article has been cited represents the extent of its impact on other publications. 16 The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. 17 The index can also be applied to the productivity and impact of a group of scientists, such as a department or university or country. 18 The data on h-index and average citations are quite telling, as it shows that although MC has significantly increased its number of publications, the average citations per article and the annual h-index are extremely low compared with the other top-ranking countries. The same result was found in publication status in the top 10 high-impact respiratory journals. This phenomenon could be explained by 2 reasons. On the one hand, MC published 2848 articles in the most recent 3 years, accounting for 45.5% (2848/6254) of the total number of articles published during 2007 to 2017.
Obviously, the longer an article is published, the more likelihood it has of being cited. On the other hand, this may reflect the fact that quality of publications from MC needs to be greatly improved. This study has some limitations that should be highlighted. First, the journals in our study were selected from the respiratory category of the 2017 SCIE, but some relevant journals were not included by SCIE. Second, some published articles in the journals included in our analysis may not be related closely to respirology, while some respiratory medicine research articles may have been published in general journals that were not included in our study. 19 Third, the IF of the journals included in our study has changed year by year. Finally, articles that showed the first author's affiliation with the 5 countries were considered as research outputs from the countries. However, some of the articles may be international cooperation efforts. Therefore, the contributions of other countries were ignored. This study provides a new perspective for current Chinese respiratory research. The number and share of articles from Chinese authors are increasing every year. Concurrently, the number of publications from the other 4 countries is growing at a slow and steady rate. These numbers are now comparable to the United Kingdom, Germany and Canada. However, the quality of articles from MC is the lowest among the 5 countries. Of note and worth mentioning is the fact that MC has published the lowest number of clinical trials and RCTs. As the second largest economy in the world with a population of over 1.3 billion, MC has great potential in the field of respirology. We suggest that Chinese respiratory researchers should spend less time writing meta-analysis and more time learning how to design and deliver RCTs. The world will benefit from even better performance in the field of respiratory research from China.
